无锡NextCODE公司联合复旦儿童医院开展罕见疾病诊断研究

  近日，无锡药明康德NextCODE公司将同上海复旦大学儿童医院合作进行全基因组和外显子组测序来诊断儿童罕见疾病；NextCOD公司将在CLIA认证和CAP公认的实验室中进行测序、分析以及数据解释，同时也可以为消费者提供基因组和表型的相关数据。
  NextCODE公司首席运营官Hannes Smarason在一份声明中表示，中国将是NextCODE公司将技术引入临床发展策略的中心。
  复旦大学儿童医院院长黄国英表示，在医学研究中利用新出现的全球化标准来进行基因组数据的分析研究，我们就可以超越静态的基因检测板来充分利用基因组治疗罕见疾病、遗传性疾病以及癌症等疾病。
  今年年初无锡药明康德公司收购了NextCODE公司，并且将其纳入基因组研究中心中，从而成立了无锡NextCODE公司，该公司总部位于上海，在剑桥市、马塞诸塞州和冰岛的雷基亚比克市均有运营区域。今年6月份，该公司还作为英格兰基因组学公司选定的四家公司中的一家，主要在英国10万人基因组研究计划中对首个8000名患者的基因组数据进行整合分析。（转化医学网360zhyx.com）

更多阅读：

药明康德收购NextCODE 创建基因医学全球领军企业
  以上为转化医学网原创翻译整理，转载请注明出处和链接！
转化医学网推荐的新闻阅读：

WuXi NextCode, Fudan Children's Hospital Collaborate on Rare Disease Diagnostics

WuXi NextCode will collaborate with the Children's Hospital of Fudan University, based in Shanghai, to offer whole-genome and exome sequencing to diagnose pediatric rare diseases, the company said today.

WuXi NextCode provides sequencing, analysis, and interpretation within a CLIA-certified and CAP-accredited laboratory. It also offers a service called NextCode Exchange that enables customers to share genomic and phenotypic data.

China is central to WuXi NextCode's strategy of bringing its technology to the clinic, Hannes Smarason, co-founder, president and COO of WuXi NextCode, said in a statement.

"Using the emerging global standard for genomic data in medicine, we can move beyond static gene panels to employ the full power of the genome to address rare diseases, genetic and genetics-related disorders, and eventually cancer and other conditions as well," Guoying Huang, president of CHFU, which serves 2.3 million patients nationwide every year, said in a statement.

WuXi NextCode was formed earlier this year when WuXi Pharma Tech bought NextCode and merged it with its genome center. WuXi NextCode has headquarters in Shanghai, with operations in Cambridge, Massachusetts and Reykjavik, Iceland.

In June it was one of four informatics companies Genomics England selected to work on interpreting genomic data from the first 8,000 patients participating in the UK 100,000 Genomes Project.